TREATMENT OF PARKINSONS-DISEASE WITH PERGOLIDE - A DOUBLE-BLIND-STUDY

被引：42
作者：
AHLSKOG, JE [1 ]
MUENTER, MD [1 ]
机构：
[1] MAYO CLIN SCOTTSDALE,DEPT NEUROL,SCOTTSDALE,AZ
来源：
MAYO CLINIC PROCEEDINGS | 1988年 / 63卷 / 10期
关键词：
D O I：
10.1016/S0025-6196(12)64911-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：969 / 978
页数：10
相关论文
共 51 条
[1]  
Barbeau A, 1974, Adv Neurol, V5, P347
[2]   BROMOCRIPTINE IN PARKINSONISM [J].
CALNE, DB ;
TEYCHENNE, PF ;
CLAVERIA, LE ;
EASTMAN, R ;
GREENACRE, JK ;
PETRIE, A .
BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5942) :442-444
[3]  
CALNE DB, 1978, LANCET, V1, P735
[4]   BROMOCRIPTINE ALONE OR ASSOCIATED WITH L-DOPA PLUS BENSERAZIDE IN PARKINSONS-DISEASE [J].
CARACENI, TA ;
CELANO, I ;
PARATI, E ;
GIROTTI, F .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1977, 40 (12) :1142-1146
[5]   DOPAMINE RECEPTOR AGONISTS - INTRINSIC ACTIVITY VS STATE OF RECEPTOR [J].
CARLSSON, A .
JOURNAL OF NEURAL TRANSMISSION, 1983, 57 (04) :309-315
[6]   DOUBLE-BLIND TRIAL OF PERGOLIDE FOR PARKINSONS-DISEASE [J].
DIAMOND, SG ;
MARKHAM, CH ;
TRECIOKAS, LJ .
NEUROLOGY, 1985, 35 (03) :291-295
[7]  
FACTOR S A, 1987, Neurology, V37, P270
[8]   ROLE OF BROMOCRIPTINE IN THE TREATMENT OF PARKINSONISM [J].
FAHN, S ;
COTE, LJ ;
SNIDER, SR ;
BARRETT, RE ;
ISGREEN, WP .
NEUROLOGY, 1979, 29 (08) :1077-1083
[9]   ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM - CLINICAL AND PHARMACOLOGIC CORRELATIONS AND EFFECT OF INTRAMUSCULAR PYRIDOXINE [J].
FAHN, S .
NEUROLOGY, 1974, 24 (05) :431-441
[10]  
GEORGE SR, 1983, J NEUROL TRANSM S, V18, P149
123456